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Abstract
The soluble TNF-like weak inducer of apoptosis (TWEAK, TNFSF12) binds to the fibroblast growth factor-inducible 14
receptor (FN14, TNFRSF12A) on the cell membrane and induces multiple biological responses, such as proliferation,
migration, differentiation, angiogenesis and apoptosis. Previous reports show that TWEAK, which does not contain a death
domain in its cytoplasmic tail, induces the apoptosis of tumor cell lines through the induction of TNFa secretion. TWEAK
induces apoptosis in human keratinocytes. Our experiments clearly demonstrate that TWEAK does not induce the secretion
of TNFa or TRAIL proteins. The use of specific inhibitors and the absence of procaspase-3 cleavage suggest that the
apoptosis of keratinocytes follows a caspase- and cathepsin B-independent pathway. Further investigation showed that
TWEAK induces a decrease in the mitochondrial membrane potential of keratinocytes. Confocal microscopy showed that
TWEAK induces the cleavage and the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus,
thus initiating caspase-independent apoptosis. Moreover, TWEAK induces FOXO3 and GADD45 expression, cdc2
phosphorylation and cdc2 and cyclinB1 degradation, resulting in the arrest of cell growth at the G2/M phase. Finally, we
report that TWEAK and FN14 are normally expressed in the basal layer of the physiological epidermis and are greatly
enhanced in benign (psoriasis) and malignant (squamous cell carcinoma) skin pathologies that are characterized by an
inflammatory component. TWEAK might play an essential role in skin homeostasis and pathology.
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Introduction
The TNF-like WEAK inducer of apoptosis (TWEAK) is a
member of the TNF ligand superfamily (TNFSF12) that was
originally described as a weak inducer of apoptosis in the IFNc-
treated HT-29 colorectal adenocarcinoma cell line [1]. TWEAK is
a type II transmembrane protein that can be cleaved to a smaller
biologically active soluble form [1,2], and it binds with high
affinity to the fibroblast growth factor-inducible 14 protein (FN14)
[3]. Results to date indicate that TWEAK homotrimers do not
bind to any other known TNFRSF member and that other known
TNFSF homotrimers do not bind FN14 [4]. FN14 (TNFRSF12A)
is distantly related to the TNF receptor (TNFR) superfamily
member TNFRSF12A, and it contains only one cysteine-rich
domain in its extracellular region and a TNFR-associated factor
(TRAF) binding domain, but no death domain (DD) in its
cytoplasmic tail [3]. The presence of a death domain in a TNFR-
type receptor is generally considered indicative of its ability to
induce apoptosis. Upon binding of its cognate ligand, a DD-
containing TNFR recruits pro-apoptotic adaptive proteins and
initiates the extrinsic pathway of apoptosis through caspase
activation. However, a number of TNFR family members that
lack canonical death domains also trigger cell death in an in vitro
setting [5,6,7,8,9,10].
Soluble TWEAK induces a variety of biological responses,
including cell growth and proliferation [11], angiogenesis [12,13],
osteoclastogenesis [14], migration [15] and apoptosis [1,16,17].
FN14 is reported as the unique signaling-competent receptor that
mediates TWEAK activity in all cell types [4].
The precise signaling pathways that lead to TWEAK-induced
cell death are not well understood but appear to involve multiple
context-dependent mechanisms, including TNF-dependent apop-
tosis [9], TNF-independent caspase-dependent apoptosis, caspase-
independent death with features of both apoptosis and necrosis,
and cathepsin B-dependent necrosis [10,11,16,18]. Previous
reports indicate that depending on the cell type, the TWEAK/
FN14 interaction activates two main pathways: the NF-kB
(canonical and alternative) signaling pathway [11,18,19,20] and
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(HEK293, MC3T3-E1) [15,21,22] signaling pathways. However,
recent studies of Kym-1 [9], HSC-3 [23] and other tumor cell lines
[24], suggest a unique caspase-dependent apoptosis mechanism
that results from an increase in TNFa secretion and its binding to
the TNFR1 receptor. These diverse and distinct TWEAK
activities are reviewed by Winkles, 2008 [25].
In a recent report describing the soluble factors implicated in
keratinocyte destruction during the onset of Lyell’s syndrome, we
have determined the presence of TWEAK in Lyell blister fluids
and have shown that TWEAK induces the apoptosis of
keratinocytes in vitro [26]. Because TNFa does not induce
apoptosis but arrests keratinocyte cell growth [27], we investigated
the mechanism of TWEAK-induced apoptosis in keratinocytes
using two different human epidermal cells, the HaCaT cell line
and normal human foreskin keratinocytes (NHK). Our data reveal
that TWEAK alone can induce normal human keratinocyte cell
death in a caspase- and cathepsin B-independent manner. In
addition, through a TNFa- independent pathway, TWEAK
induces a decrease in mitochondrial membrane potential and
the cleavage and translocation of AIF (apoptosis inducing factor)
from mitochondria to the nucleus. TWEAK also induces cdc2/
cyclinB1 complex degradation and cell growth arrest at the G2/M
phase. Finally, we report the presence of TWEAK and FN14 in
normal human epidermis and skin appendices, where they exhibit
a discrete expression, whereas their increased expression in cases
of malignant and benign lesions of human epidermis suggests a
role for TWEAK in inflammatory skin pathologies.
Results
HaCaT cells and normal human keratinocytes (NHK) bind
TWEAK through the FN14 receptor
To determine if TWEAK affects keratinocytes, we first
examined the binding of TWEAK to HaCaT cells and NHK.
Flow cytometry analysis using a FLAG-tagged human recombi-
nant TWEAK showed that TWEAK binds both HaCaT and
NHK, suggesting the expression of its receptor on the cell surface.
The use of an anti-human FN14 mAb demonstrated that FN14 is
present on the surface of both HaCaT cells and NHK (Figure 1A).
Using immunofluorescence, we detected the presence of FN14 on
the cell surface and in the Golgi apparatus of both HaCaT cells
and NHK, and a faint staining for TWEAK was observed in the
cytoplasm of these cells (Figure 1B).
TWEAK induces the apoptosis of HaCaT cells and NHK
TWEAK induces cell death in a variety of tumor cell lines by
increasing cell apoptosis [10,11,16,18]. A previous report showed
that TWEAK decreases the viability of HaCaT cells and NHK,
and that this decrease is enhanced by the simultaneous addition of
the inflammatory cytokine IFNc [26]. Therefore, we investigated
whether the decreased growth that is observed in HaCaT cells and
primary keratinocytes relies on increased apoptosis. The cells were
incubated with variable concentrations of TWEAK and/or IFNc
for 48 h. We observed a slight increase in the number of HaCaT
and NHK annexin V-single positive cells, and the number of
annexinV/PI double positive cells increased in a dose-dependent
manner. The incubation of cells with IFNc doubled the population
of annexinV single positive cells, and the number of annexinV/PI
double positive late apoptotic cells was markedly increased (8-fold
in HaCaT and 2-fold in NHK cells, respectively) compared to
controls. An additive maximal apoptotic effect was observed
following the simultaneous addition of low doses (10 ng/ml) of
TWEAK and IFNc. The results are shown in Figure 2A for
Figure 1. FN14 is present on the cell surface and binds TWEAK.
A. The HaCaT cell line and normal human keratinocytes (NHK) were
incubated in the presence of FLAG-tagged TWEAK and anti-human
FN14 FITC-conjugated mAb. Control experiments were performed using
cells incubated with buffer alone or in the presence of irrelevant mouse
IgG FITC-conjugated antibodies. TWEAK binding was detected by the
addition of the monoclonal M2 anti-FLAG antibody followed by the
addition of a PE-conjugated anti-mouse IgG goat antibody. The grey
area represents the mock control experiments, and the continuous line
represents flagged-TWEAK, and anti-FN14 bound molecules. B. HaCaT
cells and NHK were cytospun onto glass slides, were fixed and were
stained using specific anti-FN14 FITC-conjugated and anti-TWEAK Texas
red-conjugated mAbs. The slides were mounted and photographed as
described in the Materials and Methods section.
doi:10.1371/journal.pone.0033609.g001
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(NHK).
These results were confirmed by the visualization of membrane
blebbing in the NHKs after treatment with TWEAK and using a
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay. Because our culture medium contains no
recombinant EGF and a low concentration of bovine pituitary
extracts (6 mg/ml), we also examined apoptosis after the
simultaneous addition of 50 ng/ml EGF and 100 ng/ml
TWEAK. The results obtained clearly demonstrate that the
addition of EGF reverses the apoptosis that is induced by the
addition of TWEAK (Figure 2C).
TWEAK and FN14 are expressed in normal epidermis and
appendices, and their expression is increased in
inflammatory skin lesions
Using immunohistochemical staining, we investigated whether
TWEAK and/or its receptor FN14 are present in normal
epidermal structures and skin appendices (hair follicle, sebaceous
sweat glands). In normal skin, TWEAK is expressed only at the
basal layer of normal epidermis; however, its receptor FN14 is
present in the basal and in the upper (spinosal and granulosal)
layers, albeit in a heterogeneous manner. Hair follicles stain
weakly for FN14, whereas sebaceous glands and especially sweat
glands stain strongly for FN14 and TWEAK (Figure 3A).
Finally, we examined the expression of TWEAK and FN14 in
inflammatory and non-inflammatory skin pathologies. In basal cell
carcinomas TWEAK and Fn14 are highly expressed only in
palisading cells (Figure 3B). In contrast, TWEAK and FN14 are
highly expressed in squamous cell carcinoma, a tumor that is
characterized by an intense inflammatory component (Figure 3B).
In psoriasis (Figure 3C), a benign skin lesion that is characterized
by intense inflammation, the keratinocytes heavily express
TWEAK and FN14.
Death of keratinocytes observed following the addition
of TWEAK is not due to the secretion of TNFa, TRAIL or
another death-inducing TNF ligand
Previous reports have shown that the addition of TWEAK to
several tumor cell lines results in an increased production of
TNFa, which is responsible for the observed death phenomenon
[25]. In this study, we assayed by RT-PCR whether a number of
TNFSF ligands (TRAIL, FasL, LTa, EDA A1) and receptors
(TNFR1 and 2, Fas, EDAR) as well as TWEAK’s cognitive
receptor FN14 are modulated by the addition of TWEAK.. We
observed no significant increase in the mRNA expression of FasL,
LTa (lymphotoxin a) or EDA A1 ligands or TNFR1, Fas, and
EDAR receptors. Addition of TWEAK strongly stimulated the
expression of TNFa mRNA in both HaCaT and NHK, and a
smaller increase in the expression of TRAIL mRNA was detected
(Figure 4A).
The results of secretion of both TNFa and TRAIL by
keratinocytes in presence or absence of TWEAK are shown in
Table 1. TNFa secretion is very low in both HaCaT and NHK
control samples and it is not significantly modified by the addition
of TWEAK. TRAIL secretion is increased in both control HaCaT
and primary keratinocytes over the time course. However the
addition of TWEAK to HaCaT cell line, decreases TRAIL
expression as compared to that of control. For primary
keratinocytes(NHK) addition of TWEAK does not modify
significantly the secretion of TRAIL. In conclusion, the addition
of TWEAK does not increase the secretion of either TNFa and/or
TRAIL by both HaCaT cell line and primary foreskin
keratinocytes as compared to that of control samples. This was
confirmed using flow cytometry, which demonstrated the absence
of TNFa and TRAIL protein staining in the cytoplasm of both
cells following the addition of TWEAK. Finally, the incubation of
NHK with neutralizing anti-TNFa and anti-TRAIL monoclonal
Figure 2. TWEAK induces apoptosis of keratinocytes. TWEAK
induces the apoptosis of HaCaT cells (A) and NHKs (B) in a dose-
dependent manner. HaCaT cells and NHKs were incubated in culture
dishes with increasing amounts of TWEAK (10–100 ng/ml) and IFN-c
(10 ng/ml) for 48 h. The cells (including floaters) were collected and
incubated with annexinV-FITC and propidium iodide for flow cytometry
analysis. Control experiments were performed by incubating the cells in
cell culture medium. The numbers indicate the percentage of cells
within the indicated gate. The results shown are representative of three
independent experiments. C. Normal human keratinocytes were
examined under a microscope after the addition of recombinant
TWEAK (100 ng/ml) or/and EGF (50 ng/ml) for 48 h. The characteristic
membrane blebbing of the cells is shown by arrows, and quantification
was performed using the TUNEL method. P values were calculated by
comparing the treated cells to their relevant controls and were
considered significant when P,0.05.
doi:10.1371/journal.pone.0033609.g002
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viability (Figure 4C). These results suggest that under our
experimental conditions, there is no effective increase translation
and/or secretion of TNFa and TRAIL proteins upon addition of
TWEAK, and these pro-apoptotic TNFa and TRAIL ligands are
not implicated in the apoptosis of keratinocytes that is observed
following the addition of TWEAK.
We also observed a significant increase in TNFR2 and FN14
mRNA expression (Figure 4B).
TWEAK induces apoptosis through a caspase- and
cathepsin B-independent pathway
Several studies report that depending on the cell type, TWEAK-
induced cell death involves multiple mechanisms, including the
activation of cathepsin B and caspases [11,18]. We used the
general caspase inhibitor zVAD-fmk and the cathepsin B inhibitor
CA-074 to assess the role of caspases and cathepsin B in NHK and
HaCaT cell death, respectively. Before assaying for cell growth,
the cells were pre-treated with different concentrations (1, 5 and
10 mM) of either zVAD-fmk or CA-074 and were incubated at
37uC for 2 days (HaCaT) or 3 days (NHK) in the presence of
100 ng/ml TWEAK. Because the inhibitors were dissolved in
dimethylsulfoxide (DMSO), vehicle concentrations were used as
controls (0.1%, 0.05% and 0.01% DMSO). Our data demonstrate
that a concentration of 0.1% DMSO is deleterious to primary
keratinocytes (data not shown); therefore, only 1 mM and 5 mM
inhibitor concentrations were used for experiments involving
NHK. The addition of zVAD-fmk or CA-076 does not restore the
decreased cell viability caused by the addition of TWEAK
(100 ng/ml) in HaCaT or NHK cells (Figure 5A), suggesting that
the mechanisms of TWEAK-induced keratinocyte death are
independent of caspase and cathepsin B activities.
We also assayed the expression levels of several pro- and anti-
apoptotic proteins using a protein array (described in Materials
and Methods) 24 h after the addition of 100 ng/ml TWEAK to
NHKs. The results are expressed as the fold-change in expression
Figure 3. FN14 and TWEAK are detected in normal and pathological skin. Representative sections of normal epidermis, hair follicles, and
sebaceous and sweat glands (A), sections of epidermis from patients suffering from basal cell carcinoma, squamous cell carcinoma (B) and psoriasis
(C) were stained for FN14 and TWEAK. Bar represents 200 mm.
doi:10.1371/journal.pone.0033609.g003
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are presented in Figure 5B. There was no significant modification
in the expression of the pro-apoptotic proteins Bad and Bax or
cytochrome C. In contrast, the mcl-1 anti-apoptotic protein
expression decreased by ,40%, whereas expression of the anti-
apoptotic proteins Bcl-2 and Bcl-xL increased. There was a 50%
increase in the expression of pro-apoptotic FADD protein. We also
detected a decrease in the expression of c-IAP1, c-IAP2 and
SMAC, which are inhibitors of apoptosis, but there was an
increase in the expression of livin (another member of the family of
Figure 4. Modification of the expression of death ligands and receptors in keratinocytes following the addition of TWEAK. The
relative expression of TNFa and TRAIL (A), TNFR2 and FN14(B) mRNAs in HaCaT cells and NHK compared with the expression of GAPDH mRNA. The
results were normalized to the expression of control non-treated cells, which was given a value of 1. TWEAK was added at a concentration of 100 ng/
ml. C. NHK were pre-incubated with neutralizing anti-TNFa (100 ng/ml) and anti-TRAIL (100 ng/ml) monoclonal antibodies before the addition of
100 ng/ml TWEAK. Cell viability in the presence and absence of neutralizing antibodies was measured 48 h later and is expressed as a percentage of
the viability of control cells.
doi:10.1371/journal.pone.0033609.g004
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accordance with the results described above (Figure 5A), there was
no modification of pro-caspase-3 and cleaved caspase-3 expres-
sion, which indicates that caspases are not implicated in apoptosis.
Furthermore, as all these pro- and anti- apoptotic proteins
(members of bcl2 or IAP families) usually activate the cascade of
caspases, we can reasonably suggest that their modulation does not
influence the apoptosis phenomenon. No significant change in the
expression of TRAILR1, TRAILR2 and FAS, and a small
decrease in the expression of TNFR1 were observed. These data,
investigating pro-apoptotic and anti-apoptotic proteins expression,
combined to that of absence of caspase activation indicate that we
have to investigate the caspase-independent pathways of apoptosis
to find out the pathway through which keratinocytes commit to
cell death upon the addition of TWEAK.
The increase in expression observed for p21/CIP1 (3-fold
increase), and p27/Kip1 (2-fold increase) has been associated with
the arrest of cell growth at G1 [28] and G2 phases [29]. The
decrease(60%) in the expression of claspin, a cell cycle-regulated
protein that peaks at the S/G2 phase and the expression of which
is related to the function of the S phase of the cell cycle [30]. These
data may indicate a TWEAK-induced modification of cell cycle
regulation.
We have also determined whether the addition of TWEAK
induces a modification of the oxidative status of keratinocytes. In
this respect we have assayed the production of ROS (Reactive
Oxygen Species), superoxide ions, oxidized glutathione and the
modification of mitochondrial membrane potential after incuba-
tion of keratinocytes with 100 ng/ml of TWEAK. The results
Table 1. Secretion of TNFa and TRAIL by keratinocytes upon
addition of 100 ng/ml of TWEAK.
TNFa pg/ml TRAIL pg/ml
24 h 48 h 72 h 24 h 48 h 72 h
HaCaT control 16643 612 0 65 186619 346617 686616
HaCaT+TWEAK 11650 1 2 647 8 612 4 3 6123 112692
NHK control 2561.5 3260.5 N.D. 30620 350637 N.D.
NHK+TWEAK 36626 3 619 N.D. 65683 7 5 6118 N.D.
doi:10.1371/journal.pone.0033609.t001
Figure 5. Apoptosis of keratinocytes is caspase- and cathepsin B-independent. A. HaCaT cells (5.10
3 cells/well) or NHK (10.10
3 cells/well)
were incubated with the indicated concentrations of caspase (zVAD-fmk) or cathepsin B (CA-074) inhibitors for 48 h (HaCaT) or 72 h (NHK) in the
presence or absence of 100 ng/ml recombinant TWEAK. The cell viability was assessed using an MTT assay. The results are expressed as a percentage,
with the proliferation of unstimulated cells set at 100% the (mean of triplicates 6 SEM). The data are representative of three independent
experiments. TWEAK and the inhibitors were not added to the control cells; however, DMSO at a concentration equal to that in the inhibitor solutions
was added. Z=Zvad-fmk; C=CA-076; 1, 5 or 10 corresponds to 1, 5 or 10 mM, respectively; TW=TWEAK). P values were calculated by comparing the
treated cells to the relevant controls, and were considered significant when P,0.05. B. NHK were treated with 100 ng/ml TWEAK for 24 h. The cells
were lysed, and the expression of several pro- and anti-apoptotic proteins was measured as described in the Materials and Methods section. The
relative expression of these proteins compared with that of cells not treated with TWEAK is presented. The controls are considered as 100% (dotted
line).
doi:10.1371/journal.pone.0033609.g005
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result in the significant production of ROS (Figure 6A), or
superoxide ions (Figure 6B), or an increase in oxidized glutathione
levels (Figure 6C). On the contrary we have found that TWEAK
decreases significantly the mitochondrial membrane potential
(Figure 6D) of the keratinocytes, suggesting a mitochondrion –
related apoptosis..
Addition of TWEAK results in the cleavage and the
translocation of AIF (apoptosis inducing factor) from the
mitochondria to the nucleus
The data, already obtained, clearly indicate a caspase-
independent mechanism of TWEAK action in apoptosis. There-
fore, we investigated whether AIF, which is known to induce
caspase-independent apoptosis, is implicated in the TWEAK-
induced apoptosis of keratinocytes. AIF is an inner mitochondrial
membrane protein of 67 kDa, which is cleaved to a 57 kDa
species, prior to its release to the cytosol first and its consequent
translation to the nucleus in which it initiates chromatin
condensation and DNA fragmentation [31]. As shown in
Figure 7A, addition of TWEAK decreases the AIF 67 kDa species
and induces an increase of mature AIF 57 kDa species. This is
transient phenomenon with a peak at 24 h incubation of
TWEAK. Following the addition of TWEAK, a partial translo-
cation of AIF to the nucleus occurs (Figure 7B), suggesting that
AIF is implicated in the observed apoptosis phenomenon.
Addition of TWEAK induces keratinocyte G2/M growth
arrest due to cdc2 phosphorylation and cdc2 and cyclin
B1 degradation
The modification of p21, p27 and claspin expression following
the addition of TWEAK indicates a possible modulation of the cell
cycle. To investigate this hypothesis, keratinocytes were treated for
24 hours with 100 ng/ml recombinant TWEAK, and the cell
cycle was analyzed and compared to that of untreated keratino-
cytes. As shown in Figure 8A, TWEAK blocks the keratinocyte cell
cycle at the G2/M phase. The simultaneous addition of
recombinant EGF and TWEAK reverses the cell cycle growth
arrest that is observed upon the addition of TWEAK alone,
supporting the data presented in Figure 2C that demonstrates the
reversion of the TWEAK apoptotic effect by the addition of EGF.
To further analyze this effect of TWEAK on the cell cycle, we
have investigated the fate of cdc2, phosphorylated cdc2 and
cyclinB1 proteins, which control the G2/M checkpoint. The
results presented in Figure 8B clearly show that the addition of
TWEAK significantly decreases the level of cdc2 and cyclinB1
proteins and increases the level of phosphorylated cdc2, suggesting
that G2/M growth arrest is due to the degradation of the cdc2/
cyclinB complex, as previously described in primary keratinocytes
[32].
FOXO transcription factors are known to trigger a variety of
cellular processes and especially in our case , apoptosis and cell
cycle arrest by up regulating target genes as, p21, p27, Bim-1,
FASL, GADD45, 14-3-3s, depending on the environment of the
cell and the stimuli exerted on it [33]. We have already reported
that TWEAK does not increase FASL transcription and shown
that it increases the expression of p21 and p27 proteins (Figure 5B).
We have used qRT-PCR assays to investigate the expression of
FOXO3A, GADD45 and 14-3-3s mRNA, and to better define
the pathway implicated in the arrest of cell growth at the G2/M
phase. The results presented in Figure 8C show that the addition
of TWEAK, does not increase Bim 1 expression (excluding the
participation of Bim 1 in the TWEAK-induced apoptosis of
keratinocytes) while it increases significantly the expression of
Figure 6. TWEAK decreases the mitochondrial membrane potential of keratinocytes. NHK were treated with TWEAK (100 ng/ml) and ROS
(A), and superoxides (B), oxidized glutathione (C) and the mitochondrial membrane potential (C) was measured as indicated in the Materials and
Methods section.
doi:10.1371/journal.pone.0033609.g006
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the first time in our knowledge that the addition of TWEAK
increases the transcription of FOXO3A. GADD45 [34,35,36] and
14-3-3s [37] are known to bind to cdc2 inhibiting the kinase
activity and induce cell growth arrest at G2/M phase.
Discussion
The tumor necrosis factor superfamily (TNFSF) consists of
ligands that mediate their effect through the engagement of TNF
receptor superfamily (TNFRSF) members. Members of the
TNFRSF, which contain a specific ‘‘death domain’’ sequence in
their cytoplasmic tail, recruit adaptor proteins that trigger caspase
activation and result in the activation of the extrinsic pathway of
apoptosis. The TNF-like weak inducer of apoptosis (TWEAK,
TNFSF12) is a relatively new member of this superfamily [1] that
Figure 7. AIF translocates to the nucleus following the addition
of TWEAK. A. NHK cells were incubated with TWEAK (100 ng/ml). The
cells were lysed at various time intervals and were analyzed by Western
blotting with a rabbit polyclonal anti-AIF specific antibody. B. The
control cells were left untreated. The cells were detached, placed on
glass slides, fixed with paraformaldehyde, permeabilized with Triton X-
100 and stained with a rabbit polyclonal anti-AIF antibody. The bands
were visualized using donkey anti-rabbit F(ab)92 FITC polyclonal
antibody. The nucleus was stained with DAPI.
doi:10.1371/journal.pone.0033609.g007
Figure 8. TWEAK induces the cell growth arrest of keratino-
cytes and the degradation of the cdc2/cyclin B1 complex, and
activates FOXO3A, GADD45 and 14-3-3s. A. NHK cells were
treated with TWEAK (100 ng/ml) or TWEAK and EGF (50 ng/ml) for 24 h.
The nuclei were isolated, were stained using propidium iodide and the
cells were counted using flow cytometry. The results were analyzed
using a ModFit program. Untreated cells were used as controls. B. NHK
cells were incubated with TWEAK (100 ng/ml). The cells were lysed at
various time intervals and were analyzed by Western blotting with anti-
cyclin B1, anti-cdc2 and anti-phospho-cdc2 specific antibodies. C. NHK
cells were treated with TWEAK (100 ng/ml) for 24, 48 and 72 hours. The
cells were lysed, and the RNA was isolated. A quantitative RT-PCR assay
using specific primers for FOXO3A, GADD45, Bim-1 and 14-3-3s mRNAs
was used to measure the expression of these genes. GAPDH mRNA
expression was used to normalize the results, which are expressed as a
fold increment compared to that of the control sample, which was
given a value of 1. A statistical analysis (the Student’s t-test) was
performed and the results were considered significant when P,0.05.
doi:10.1371/journal.pone.0033609.g008
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of physiological [4,25] and pathological processes [38], such as
growth, differentiation and/or apoptosis. The FN14 receptor does
not contain a ‘‘death domain’’ that directly triggers apoptosis.
Previous studies suggest that the addition of TWEAK results in an
increase in the secretion of TNFa, which binds to TNFR1 and
triggers the extrinsic pathway of apoptosis [9,23,24]. In this study,
we have shown that recombinant FLAG-tagged TWEAK binds its
FN14 receptor on the surface of HaCaT cells and NHKs,
suggesting that human keratinocytes express cell surface FN14 and
may therefore respond to TWEAK stimulation. TWEAK
treatment induced the apoptosis of HaCaT cells and NHKs.
Because the addition of TNFa results in only cell growth arrest, in
these cells [27], we have investigated mechanisms that govern the
pro-apoptotic action of TWEAK.
A recent study [39] suggests that TWEAK alone cannot induce
the apoptosis of keratinocytes, whereas we have shown that
TWEAK induces a 26% and 38% apoptosis in the HaCaT cell
line and NHK respectively. The discrepancy in these results is due,
in our opinion, to the factors introduced in the keratinocyte culture
medium; SFM medium used in the previous study [39] contained
5 ng/ml EGF and 50 mg/ml bovine pituitary extracts, whereas
our CnT-57 medium contains only 6 mg/ml of bovine pituitary
extracts and no EGF. Following the addition of EGF, we show that
the pro-apoptotic effect of TWEAK is abolished, supporting our
hypothesis. Moreover, TWEAK induces apoptosis of the HaCaT
cell line, which is grown in a medium that does not contain EGF.
Furthermore, we have investigated whether the addition of
TWEAK triggers an increase in the expression and secretion of
TNFa, as proposed in other reports [9,23,24]. We have extended
our study to include the death ligands TRAIL, FasL, LTa and
EDA-A1 and their corresponding receptor mRNAs. The results
confirm that TWEAK induces an increase in TNFa mRNA
expression and a small increase in TRAIL mRNA expression.
Surprisingly, the increases in the mRNA expression levels do not
result in an increase in the amount of TNFa and TRAIL proteins
secreted by HaCaT cells and NHK following incubation with
TWEAK. Furthermore, the addition of neutralizing antibodies
does not restore the viability of the cells. This latter fact excludes
TNFa and/or TRAIL as the potential mediators of TWEAK-
induced apoptosis. Our results that pan-caspase and cathepsin B
inhibitors do not restore the viability of keratinocytes and the
observation that caspase-3 is not activated strengthen the
suggestion that the TWEAK-induced apoptosis of keratinocytes
is caspase- and cathepsin B-independent and that TNFa and
TRAIL, which induce caspase activation when bind their
corresponding receptors, do not mediate TWEAK-induced
apoptosis.
Because it is clear that the apoptosis observed is caspase-
independent and that TWEAK induces changes in the mitochon-
drial potential, we have investigated the implication of the
translocation of apoptosis inducing factor (AIF), which is known
to induce caspase-independent apoptosis [31,40] from the mito-
chondria to the nucleus. We showed that addition of TWEAK
results in cleavage of membrane bound AIF, a prerequisite step for
the translation of AIF from mitochondria to nucleus [31]. Confocal
microscopy demonstrating the translocation of AIF to the nucleus
suggests that AIF is responsible for the caspase-independent
apoptosis observed in keratinocytes. The AIF activation mechanism
that is reported here for the first time may explain previous results
demonstrating a caspase-independent apoptosis in different cell
lines following the addition of TWEAK [10].
We have shown that TWEAK induces cell growth arrest at G2/
M through both the transcription of FOXO3A, GADD45 and 14-
3-3s, and the degradation of the cdc2/cyclinB1 complex.
GADD45 inhibits the kinase activity by binding to cdc2
[34,35,36] and 14-3-3s by sequestering cdc2/cyclinB1 complex
in the cytosol [37]. Furthermore we have observed the increase of
p21 and p27 proteins known to inhibit cdc2 kinase and to induce a
G2/M growth arrest [41,42]. Here, we are in presence of
activation of more than one mechanism that could be involved in
the G2/M growth arrest observed. Further investigation is
necessary to estimate the relative importance of each mechanism
implicated in keratinocyte growth arrest.
Because the addition of EGF abolishes the cell growth arrest
and apoptosis observed after the addition of TWEAK, this
suggests that cell growth arrest and apoptosis are related, with cell
growth arrest preceding apoptosis.
The data reported in this paper suggest that TWEAK-induced
apoptosis of keratinocytes is caspase-independent and takes place
through opening of mitochondrial membrane cleavage and
translocation of AIF to the nucleus. Work is in progress in our
group to better define the molecular basis of the correlation
between G2/M cell growth arrest and the apoptosis observed.
TWEAK and FN14 are present in the normal epidermal
structure and skin appendices (hair follicle, sebaceous gland and
sweat gland), and an increased expression of TWEAK and FN14 is
found in inflammatory benign and malignant skin conditions, such
as psoriasis and squamous cell carcinoma. The data suggest that
TWEAK and FN14 are involved in skin physiology. Notably, a
similar high level of TWEAK and FN14 expression has been
reported in renal tubules [43] and in a number of vessels,
suggesting that TWEAK is involved in secretory processes. A
recent report [26] shows that TWEAK is involved in the death of
keratinocytes in toxic epidermal necrolysis. Taken together with
the data presented here that demonstrates the direct pro-apoptotic
effect of TWEAK in human keratinocytes, this study strengthens
our hypothesis that TWEAK plays a role in immune and/or
remodeling reactions in healthy and in pathological skin.
Materials and Methods
Cells and reagents
The HaCaT cell line is a keratinocyte-derived cell line [44].
HaCaT cells were grown in Dulbecco’s modified minimal essential
medium (DMEM) supplemented with 10% fetal calf serum (FCS)
and 5 mg/ml plasmocin
TM (Cayla, Toulouse, France) antibiotic.
In the viability assays, DMEM was replaced with RPMI 1640
medium for optical density measurement considerations. Normal
human foreskin keratinocytes (NHK) were grown in pre-coated
plastic dishes containing EpilifeH medium that was supplemented
with defined growth supplement (EDGS), according to the
manufacturer’s instructions. For routine subculture, a synthetic
coating mix was used; 96-well plates were prepared using a
collagen gel that was reconstituted from an acid soluble rat-tail
collagen I solution. All media and supplements were purchased
from Invitrogen (Cergy Pontoise, France), with the exception of
soluble rat-tail collagen I, which was purchased from BD
Biosciences (Le Pont de Claix, France). CnT-57 medium
(CellnTec, Bern, Switzerland) was also used for keratinocyte
culture, which does not require the flasks to be coated with
collagen. The results obtained using the two different media were
similar. The cells were maintained at 37uC in an atmosphere
containing 5% CO2.
The following ligands and antibodies were used: human FLAG-
tagged TWEAK and human IFNc were from Enzo Life Sciences
(Villeurbanne, France); mouse neutralizing anti-human TNFa
(BC7) and anti-human TRAIL (B-T24) were from Diaclone
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and mouse mAb anti-FLAG antibody M2 were from Sigma-
Aldrich (St. Quentin Fallavier, France). PE-conjugated goat
F(ab9)2 anti-mouse IgG antibody from Beckman Coulter was used
for the FN14 cell surface expression experiment, and FITC-
conjugated mouse mAb (ITEM-4) anti-human FN14 from Santa
Cruz Biotechnology (Covalab, Paris, France) and FITC-conjugated
mouse IgG2b were used as isotype controls. Rabbit polyclonal anti-
human AIF (1/100) (CST, Ozyme) was used and was visualized
using a FITC-conjugated goat anti-rabbit F(ab)92 (1/50) antibody
(Immunotech, Marseille, France). All antibodies were tested with
known positive and negative control samples before use.
Cell viability assay
HaCaT cells (5610
3 cells per well) and NHK (10.10
3 cells per
well) were incubated with increasing amounts (10–100 ng/ml) of
TWEAK in the presence or absence of IFNc (10 ng/ml) for 3–4
days in flat-bottom 96-well microtiter plates. Cell viability was
determined by measuring the metabolic activity using an MTT (3-
(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) as-
say. Briefly, 20 ml of a 5 mg/ml MTT solution was added to each
well. Following a 4 h incubation at 37uC, the cells were lysed by
the addition of 100 ml of lysis buffer (20% SDS and 50% DMF)
and were incubated O/N at 37uC. Following the measurement of
the optical density at 590 nm, the results were analyzed. The
assays were performed in triplicate.
For the inhibition experiments, the cells were mixed with 1–
10 mM zVAD-fmk and CA-074 for 10 minutes prior to dilution
into the growth medium to yield a final concentration of between 1
and 10 mM during the growth phase. Stock solutions (10 mM) of
zVAD-fmk and CA-074 inhibitors were in DMSO, and
corresponding DMSO concentrations were run as controls in all
experiments.
HaCaT cells were pre-treated with 100 ng/ml of neutralizing
anti-TNFa and/or anti-TRAIL monoclonal antibodies, before the
addition of the different cytokines.
Apoptosis
After treatment, keratinocytes were trypsinized, were combined
with floating cells and were then counted. The cells (2.10
4) were
suspended in annexinV binding buffer and were stained with 5 ml
annexinV-FITC (Bender Medsystems, Vienna, Austria) and 10 ml
propidium iodide (PI) for 10 min at room temperature in the dark.
The cells were analyzed immediately using a Coulter EPICS XL
flow cytometer and the data were analyzed using Win MDI
software. Apoptotic cells were identified as annexinV
+/PI
2 (early
apoptotic cells) and annexinV
+/PI
+ (late apoptotic cells). Each
experiment was repeated at least three times.
Apoptosis was also quantified by the direct visualization of the
cells under 106 magnification, and the apoptotic cells were
counted and identified by the presence of characteristic membrane
blebbing and nuclear chromatin condensation. Additionally, the
indirect TUNEL enzymatic labeling technique was used to detect
apoptotic cells using an in situ cell death detection kit with alkaline
phosphatase (AP) (Boehringer Mannheim, Germany).
A human apoptosis array kit (R&D Systems, Lille, France) was
used to measure the level of expression of pro- and anti-apoptotic
proteins before and after the addition of TWEAK.
Receptor-ligand binding assay
After detachment, the cells (1.10
6) were incubated in cell culture
medium containing 10% normal human AB serum for 30 min at
4uC. FLAG-TWEAK was added to a final concentration of
100 ng/ml. FACS buffer (1 mM EDTA, 1% BSA and 0.2%
NaN3 in PBS) was used as a mock control. The binding of
TWEAK was detected by the sequential addition of monoclonal
mouse anti-FLAG M2 antibody and PE-conjugated goat F(ab9)2
anti-mouse IgG antibody (1/50). Fluorescence was analyzed using
a Beckman-Coulter Cytomics FC 500 cytometer and WinMDI
software to detect the binding of FLAG-TWEAK and fluorescent
antibodies on the surface of the cells.
Cell cycle analysis
NHK cells were treated with TWEAK (100 ng/ml) or TWEAK
and EGF(50 ng/ml)for 24 h, were harvested, were washed in PBS-
EDTA and were incubated for at least 2 hours at 4uC in a 30 mM
sodium citrate buffer, pH 7.6, containing 0.1% Nonidet P-40,
50 mg/ml RNAse A and 50 mg/ml propidium iodide. The cells
were assayed using flow cytometry in a Becton-Dickinson
FACSCanto II cytometer and the data were analyzed using ModFit
LT (Verify Software, Topsham, MN) software. The experiments
were repeated three times. Untreated cells were used as controls.
ELISA
HaCaT cells (500610
3/well) and NHK (1610
6) were incubated
with TWEAK (100 ng/ml) for 3 (HaCaT) or 2 (NHK) days in 6-
well flat bottom plates. The amount of TNFa and TRAIL secreted
into the supernatants was measured using the corresponding ELISA
kits(Elipair,Diaclone),accordingtothemanufacturer’sinstructions.
Quantitative RT-PCR
Total RNA was isolated from cell cultures using a miniprep
RNA isolation kit (Qiagen, Hilden, Germany). RNA (1 mg) was
subjected to the Thermoscript RT-PCR (Invitrogen) assay. Real-
time PCR using SYBR Green was performed using a Power
SYBR Green qPCR kit (Applied Biosystems, Warrington, UK)
according to the manufacturer’s instructions and a 7300 Real
Time PCR System (Applied Biosystems). The primers were
designed using Primer Express 3.0 software (Applied Biosystems).
Primers were synthesized by Invitrogen.
TNFa forward (fwd) CCCAGGCAGTCAGATCATCTTC,
reverse (rev) GGTTTGCTACAACATGGGCTACA;
TRAIL fwd CAGAGGAAGAAGCAACACATTGTC, rev
GCGGCCCAGAGCCTTT;
LTa fwd GCCTTGGTTCTCCCCATGA, rev GTGTAGG-
GTGGTGCCACACA;
GAPDH fwd TGGGTGTGAACCATGAGAAGTATG, rev
GGTGCAGGAGGCATTGCT;
EDA A1 fwd GCCAAGGGTCAGCAATTCA, rev TGATGC-
GAGACCAGTCATTGA;
FASLG fwd CCCATTTAACAGGCAAGTCCAA, rev GC-
AGGACAATTCCATAGGTGTCT; 14-3-3s fwd CAAAGA-
CAGCACCCTCATCATG, rev TCGGCCGTCCACAGTGT;
Bim1 fwd GGCTGCCAGACAAGGTCAA, rev TTTATTCA-
GAGCTGGAGCAACAAG; GADD45A fwd TTGCAATAT-
GACTTTGGAGGAATTC, rev CCCCCACCTTATCCATCC-
TT; FOXO3 fwd ACGGCTCACTCTGTCCCAGAT, rev
TGTCGCCCTTATCCTTGAAGTAG.
The reaction conditions for real-time PCR were 95uC for
10 min, followed by 40 cycles of 95uC for 15 sec and 60uC for
60 sec. Changes in expression levels were normalized to control
GAPDH RNA levels. Each set of primers was tested with at least
three different RNA samples that were treated independently.
Tissue selection
Specimens of normal human skin (n=20), basal (n=10) and
squamous cell carcinoma (n=10) and psoriasis (n=9) wereobtained
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Pathology Tissue Bank, and permission was obtained from the
University Hospital Research and Ethics Committee. Slides were
prepared with serial sections of tissue (3 mm): one sample for
hematoxylin-eosin staining and two for the specific immunostaining
of TWEAK and FN14. The slides were reviewed blindly by two
independent investigators who came to a consensus.
Immunohistochemistry
After deparaffinization and hydration, the slides (in citrate
buffer; 0.01 M, pH 6.0) were subjected to three cycles (5 min
each) of incubation in a microwave oven (500 W) and were treated
with EDTA buffer (15 min). The specific antibodies used were
TWEAK (sc-12405 goat polyclonal antibody, 1/100 dilution) and
Fn14 (mouse monoclonal, sc-56250, dilution 1/50, both from
Santa Cruz Biotechnology, CA, USA). A K-1500 CSA kit
(DAKO, Glostrup, Denmark) was used for the immunodetection
of TWEAK and Fn14. Counterstaining was performed using
Mayer’s hematoxylin. Known positive and negative controls
(omission of the primary antibody) were used in each experiment
, as previously described [45].
Measurement of the mitochondrial membrane potential,
total ROS, superoxide and oxidized glutathione levels
The mitochondrial membrane integrity was evaluated using a
rhodamine 123 (R123) stain. This cationic fluorescent dye
concentrates in the membrane of functional mitochondria because
of the high negative electrical potential across the mitochondrial
inner membrane [46,47], which is proportional to the mitochon-
drial membrane potential (DYm). After a 3-hour treatment with
0.02 mM, 0.2 mM or 2 mM H2O2, the cells were detached from
the culture flasks and were diluted in PBS (1610
6 cells/ml). The
cells were incubated in R123 at 1 mM for 15 min at room
temperature and were assayed using flow cytometry and a
Beckton-Dickinson FACSArray apparatus (Becton-Dickinson,
Franklin Lakes, NJ). The data were analyzed using CELLQuest
(Beckton-Dickinson) software.
Total ROS (reactive oxygen species) and superoxides were
measured using a Total ROS/Superoxide detection kit (Enzo Life
Sciences).
Oxidized glutathione levels were measured as previously
described [48].
Western blot analysis
The Western blots were prepared and incubated as previously
described [26], were visualized using chemiluminescent reagents
(Thermo Fischer Scientific, Brebie `res, France) and were quantified
using an ImageQuant LAS 4000 apparatus (GE Health Care,
Orsay, France). All primary antibodies were used at a dilution of
1/1000 and were purchased from CST, Ozyme (St Quentin en
Yvelines, France), except for mcl-1, which was purchased from
Abcam (Cambridge, UK). The antibodies used were mouse anti-
human cyclinB1 mAb, rabbit anti-human phospho cdc2 mAb,
mouse anti-human cdc2 mAb, and rabbit anti-human AIF
polyclonal antibody. Secondary HRP-conjugated anti-mouse
IgG (1/1000) and anti-rabbit IgG (1/2000) were used to visualize
the proteins (Jackson ImmunoResearch, Baltimore, PA, USA).
Confocal microscopy
The cells were fixed on glass slides as previously described.
Images were acquired by confocal microscopy on a Zeiss LSM 510
META confocal laser microscope (Zeiss, Oberkochen, Germany)
with a Plan Apochromat 636 N.A.1.4 oil-immersion objective
using LSM510 software v4.0 (Zeiss). To restore image quality, the
images were processed using AutoDeblur 2D deconvolution
software (AutoQuantr, Watervliet, NY), which uses blind iterative
algorithms.
Data analysis
The results are expressed as the mean 6 SD, and the statistical
analysis was performed using the Student’s t-test. Differences were
considered significant when P,0.05.
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